Vicente Pelechano Garcia
Principal Researcher | Docent
E-mail: vicente.pelechano.garcia@ki.se
Visiting address: Tomtebodavägen 23A (Gamma5), 17165 Solna
Postal address: C1 Mikrobiologi, tumör- och cellbiologi, C1 SciLife Pelechano, 171 77 Stockholm
About me
- 2003 Biochemistry Graduate. University of Valencia [1], Spain.
2009 PhD in Molecular Biology.University of Valencia [2], Spain.
2009-2012 Postdoctoral training at EMBL Genome Biology Unit [3]. Heidelberg.
Germany
2012-2015 Staff Scientist at EMBL Genome Biology Unit [4]. Heidelberg.
Germany
2016-2020 Assistant Professor and Group Leader. Karolinska Institutet.
Department of Microbiology, Tumor and Cell Biology (MTC)
[1] https://www.uv.es
[2] https://www.uv.es
[3] https://www.embl.org
[4] https://www.embl.org
Research
- *Genomic dissection of non-genetic cellular heterogeneity*
One of the biggest challenges in biology is to understand how apparently
identical cells respond differently to the same stimulus. In some cases, this
differential behaviour can be explained by alterations of their genetic
material, however in other cases identical (clonal) cells can also display
phenotypically heterogeneous responses. We use state of the art genomic
technologies to study the regulatory mechanism leading to the appearance of
divergent gene expression programs in clonal population.
In the last decades, the biomedical field has suffered a revolution thanks to
the development of the massive parallel sequencing technologies. Now we can
obtain the complete genetic information of a person and analyse how this
information is being used in a few days and with a limited cost. This
technology makes possible a kind of research that was unthinkable a few years
back. Our group, combining experimental and computational work, aims to
develop and apply novel genome-wide techniques to address fundamental
biological questions with medical implications. We are especially interested
in how subtle variations in gene expression can lead to differential cellular
phenotypes in humans and microorganism. Specifically, we investigate:
*1. Molecular bases of non-genetic cellular heterogeneity:* We focus on
understanding how single-cell variability, cellular plasticity and
transcriptional memory contribute to the appearance of drug-tolerant cancer
persister cells (i.e. those cells that, although genetically sensitive to a
drug, do not respond to it). To reach that goal we combine the dissection of
genetic factors controlling non-genetic heterogeneity with the development of
novel genome-wide technologies to study this process.
*2. Crosstalk between ribosome dynamics and mRNA degradation.* We have
previously shown how the existence of widespread co-translational mRNA
degradation allows to study ribosome dynamics by sequencing mRNA degradation
intermediates (5P-Seq). Using that work as staring point, we to dissect the
molecular crosstalk between mRNA degradation and ribosome dynamics in
multiple organisms. We are characterizing how alterations in the translation
process modulates mRNA stability and explore the utility of mRNA degradation
signatures as reporters for cellular fitness in multiple organisms (from
bacteria to cancer cells). We are particularly interested to use this
technology as a new molecular reporter to investigate antibiotic response in
complex bacterial samples.
*3. Novel tools for molecular diagnosis.* We are using our genomics expertise
to improve and develop new molecular diagnosis and clinical genomic tools. We
develop sequencing-based approaches to improve cancer-patient stratification
and to accelerate the diagnosis of antimicrobial resistant infections.
Our group is affiliated to MTC and the Science for Life Laboratory
(http://scilifelab.se/ [1]) where our lab is located. External group
homepage: http://pelechanolab.com [2]
Photo credit of my portrait: /Magnus Bergström/
[1] http://scilifelab.se/
[2] http://pelechanolab.com/
Teaching
- Since 2018 I co-direct the Karolinska PhD course “Genomics for Biomedical
scientist: Handle your gene expression data (3230)”, co-directed with my
MTC/SciLifeLab colleague Dr. Claudia Kutter [1].
In addition, I teach in multiple Master and PhD courses in the field of
Genomics, Gene Expression and Epigenetics.
[1] https://ki.se/en/mtc/kutter-group-regulatory-transcriptions
Articles
- Article: NUCLEIC ACIDS RESEARCH (NAR). 2024;52(19):12005-12020
- Article: YEAST. 2024;41(7):458-472
- Article: MOLECULAR SYSTEMS BIOLOGY. 2024;20(5):506-520
- Article: NATURE COMMUNICATIONS. 2024;15(1):2744
- Article: BIOCHIMICA ET BIOPHYSICA ACTA - GENE REGULATORY MECHANISMS. 2024;1867(1):194995
- Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2024;121(7):e2310479121
- Article: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2023;25(1):507
- Article: SCIENCE ADVANCES. 2023;9(36):eadi4997
- Journal article: HEMASPHERE. 2023;7(Suppl):e08711d7
- Article: NATURE MICROBIOLOGY. 2023;8(6):1123-1136
- Article: NATURE CANCER. 2023;4(3):344-364
- Article: GENOME BIOLOGY. 2023;24(1):30
- Article: NATURE COMMUNICATIONS. 2023;14(1):910
- Article: NATURE COMMUNICATIONS. 2022;13(1):1860
- Article: NAR GENOMICS AND BIOINFORMATICS. 2022;4(2):lqac048
- Article: CELL REPORTS. 2021;36(9):109633
- Article: LAB ON A CHIP. 2021;21(15):2932-2944
- Article: RNA BIOLOGY. 2021;18(8):1206-1220
- Article: HELIYON. 2021;7(7):e07584
- Article: CLINICAL MICROBIOLOGY AND INFECTION (CMI). 2021;27(7):1036.e1-1036.e8
- Article: STAR PROTOCOLS. 2021;2(2):100447
- Article: CELL REPORTS: METHODS. 2021;1(1):100001
- Article: SCIENTIFIC REPORTS. 2021;11(1):1820
- Article: GENOME BIOLOGY. 2021;22(1):34
- Article: NUCLEIC ACIDS RESEARCH (NAR). 2021;49(1):206-220
- Article: NAR GENOMICS AND BIOINFORMATICS. 2020;2(4):lqaa099
- Article: NUCLEIC ACIDS RESEARCH (NAR). 2020;48(18):e104
- Article: NUCLEIC ACIDS RESEARCH (NAR). 2020;48(15):8509-8528
- Article: SCIENTIFIC REPORTS. 2020;10(1):13513
- Article: NATURE COMMUNICATIONS. 2020;11(1):2589
- Article: GENOME RESEARCH. 2019;29(12):1974-1984
- Article: MOLECULAR CELL. 2019;74(1):196-211.e11
- Article: PLOS GENETICS. 2019;15(2):e1007969
- Article: EMBO JOURNAL. 2018;37(23):e99179
- Article: PLOS GENETICS. 2018;14(7):e1007563
- Article: NATURE COMMUNICATIONS. 2018;9(1):1107
- Article: METHODS IN MOLECULAR BIOLOGY. 2018;1689:177-194
- Article: NUCLEIC ACIDS RESEARCH (NAR). 2017;45(16):9302-9318
- Article: NUCLEIC ACIDS RESEARCH (NAR). 2017;45(12):7326-7338
- Article: SCIENCE. 2016;353(6306):aaf1420
- Article: NATURE GENETICS. 2016;48(9):984-994
- Article: NATURE STRUCTURAL & MOLECULAR BIOLOGY. 2016;23(6):580-589
- Article: NUCLEIC ACIDS RESEARCH (NAR). 2016;44(8):3643-3658
- Article: BIOCHIMICA ET BIOPHYSICA ACTA: INTERNATIONAL JOURNAL OF BIOCHEMISTRY AND BIOPHYSICS. 2016;1859(5):731-743
- Article: CELL REPORTS. 2016;14(10):2463-2475
- Article: NATURE PROTOCOLS. 2016;11(2):359-376
- Article: METHODS IN MOLECULAR BIOLOGY. 2016;1361:125-139
- Article: METHODS IN MOLECULAR BIOLOGY. 2016;1358:295-302
- Article: CELL REPORTS. 2015;12(1):128-139
- Article: CELL. 2015;161(6):1400-1412
- Article: MOLECULAR SYSTEMS BIOLOGY. 2015;11(6):812
- Article: NUCLEIC ACIDS RESEARCH (NAR). 2015;43(2):787-802
- Article: MOLECULAR SYSTEMS BIOLOGY. 2015;11(1):777
- Article: NATURE PROTOCOLS. 2014;9(7):1740-1759
- Article: NATURE STRUCTURAL & MOLECULAR BIOLOGY. 2014;21(6):560-568
- Article: BMC GENOMICS. 2014;15(1):247
- Article: MOLECULAR SYSTEMS BIOLOGY. 2014;10(2):719
- Article: NATURE STRUCTURAL & MOLECULAR BIOLOGY. 2013;20(8):923-928
- Article: NATURE. 2013;497(7447):127-131
- Article: NUCLEIC ACIDS RESEARCH (NAR). 2013;41(5):e65
- Article: MOLECULAR CELL. 2012;47(2):267-280
- Article: TRANSCRIPTION. 2012;3(1):39-44
- Article: GENETICS. 2011;189(4):1235-1248
- Article: COMPTES RENDUS - BIOLOGIES. 2011;334(8-9):647-654
- Article: METHODS IN MOLECULAR BIOLOGY. 2011;734:25-44
- Article: PLOS ONE. 2010;5(11):e15442
- Article: NUCLEIC ACIDS RESEARCH (NAR). 2010;38(14):4651-4664
- Article: YEAST. 2010;27(7):413-422
- Journal article: NEW BIOTECHNOLOGY. 2010;27:s48
- Article: PLOS GENETICS. 2009;5(8):e1000614
- Article: YEAST. 2008;25(2):85-92
- Article: YEAST. 2006;23(9):689-699
- Show more
All other publications
- Corrigendum: NATURE COMMUNICATIONS. 2024;15(1):4752
- Preprint: PREPRINTS.ORG. 2023
- Corrigendum: NATURE COMMUNICATIONS. 2023;14(1):5019
- Preprint: BIORXIV. 2023
- Preprint: BIORXIV. 2023
- Preprint: BIORXIV. 2022
- Preprint: BIORXIV. 2022
- Preprint: BIORXIV. 2021
- Corrigendum: GENOME BIOLOGY. 2021;22(1):46
- Review: METHODS IN ENZYMOLOGY. 2021;655:85-118
- Preprint: MEDRXIV. 2020
- Letter: CLINICAL CHEMISTRY. 2020;66(7):975-977
- Preprint: BIORXIV. 2020
- Preprint: BIORXIV. 2020
- Preprint: BIORXIV. 2019
- Preprint: BIORXIV. 2019
- Preprint: BIORXIV. 2018
- Preprint: BIORXIV. 2018
- Corrigendum: NATURE COMMUNICATIONS. 2018;9(1):2071
- Preprint: BIORXIV. 2018
- Review: YEAST. 2017;34(12):475-482
- Editorial comment: ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY. 2017;1008:V-VI
- Preprint: BIORXIV. 2015
- Conference publication: THE FEBS JOURNAL. 2015;282:210
- Corrigendum: PLOS ONE. 2014;9(12):e115560
- Review: NATURE REVIEWS GENETICS. 2013;14(12):880-893
- Corrigendum: NUCLEIC ACIDS RESEARCH (NAR). 2013;41(12):6370
- Review: METHODS IN ENZYMOLOGY. 2012;513:271-296
- Review: TRENDS IN GENETICS. 2011;27(7):267-276
- Show more
Grants
- Swiss National Science Foundation1 April 2022 - 31 March 2026
- VINNOVA1 January 2021 - 30 September 2024
- Swiss National Science Foundation1 April 2017 - 31 March 2021
Employments
- Principal Researcher, Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, 2022-
Degrees and Education
- Docent, Karolinska Institutet, 2023